Substance / Medication

Tadalafil

Overview

Active Ingredient
tadalafil
RxNorm CUI
358263
Labeler: Bostal LLCUpdated: 2026-02-04T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

55 trials linked to this intervention

55
Total Trials
13
Recruiting
16
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Is silodosin better than tadalafil as a medical expulsive therapy in lower ureter stones?
Abdalaziz Mohab Alsaid Saad, Hanafi Yousif Ahmad, Hamed Belal Mohamed et al. · Arch Ital Urol Androl · 2025
PMID: 40247733Meta-Analysis
Pooled-analysis of tadalafil and tamsulosin for ureteral calculi.
Sun Fengze, Liu Hongquan, Wu Gang et al. · Front Pharmacol · 2024
PMID: 38873423Meta-AnalysisFull text (PMC)
Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review.
Shafiee Arman, Bahri Razman Arabzadeh, Teymouri Athar Mohammad Mobin et al. · BMC Gastroenterol · 2023
PMID: 37217851Meta-AnalysisFull text (PMC)
Chinese herbal medicine combined with tadalafil for erectile dysfunction: a systematic review and meta-analysis.
Wang Y L, Geng L G, He C B et al. · Andrology · 2020
PMID: 31464074Meta-Analysis
Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis.
Wang Yilin, Bao Yiping, Liu Jie et al. · Low Urin Tract Symptoms · 2018
PMID: 29341503Meta-Analysis
Tadalafil Facilitates the Distal Ureteral Stone Expulsion: A Meta-Analysis.
Bai Yunjin, Yang Yubo, Wang Xiaoming et al. · J Endourol · 2017
PMID: 28384011Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tadalafil (substance)
SNOMED CT
407111005
UMLS CUI
C1176316
RxNorm CUI
358263
Labeler
Bostal LLC

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
55
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.